Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & scope
    • Editorial Board
    • Contact Information
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Publication Ethics and Malpractice Statement
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
Correction: GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study
Mani Ramzi, Aliraza Rezvani, Mehdi Dehghani
Published: 2015-10-01
Association between TLR2 and TLR4 Expression and Response to Induction Therapy in Acute Myeloid Leukemia Patients
Mani Ramzi, Abolfazl Khalafi-Nezhad, Mahdiyar Iravani Saadi, Zahra Jowkar
Published: 2018-07-29
GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study
Mani Ramzi, Aliraza Rezvani, Mehdi Dehghani
ESHAP versus IEV Chemotherapy for Relapsed or Refractory Hodgkin's and Non- Hodgkin's Lymphoma
Mehdi Dehghani, Reza Vojdani, Abolfazl Khalafi-Nezhad, Mohammad Reza Ravanbod, Mani Ramzi, Shima Dehdashti, Erfan Taheri Fard, Nasrin Namdari
Published: 2025-04-20
Evaluating the Efficacy of Modified BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Regimen as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma: An Experience from Two Centers of a Developing Country
Mani Ramzi, Elaheh Vafaie, Hourvash Haghighinejad, Hashim Imran
Published: 2023-04-17
Evaluation of Reversed Administration Order of Busulfan (BU) and Cyclophosphamide (CY) as Conditioning on Liver Toxicity in Allogenic Hematopoietic Stem Cell Transplantation (ALL-HSCT)
Mani Ramzi, Nasrin Namdari, Shirin Haghighat, Hourvash Haghighinejad
Published: 2020-07-02
1 - 6 of 6 items


2023 CiteScore: 1.3

pISSN: 2008-3009
eISSN: 2008-2207

Editor-in-Chief:
Ardeshir Ghavamzadeh, MD.

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

1.3
2023CiteScore
 
 
36th percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
International Journal of Hematology-Oncology and Stem Cell Research (Quarterly), pISSN: 2008-3009, eISSN: 2008-2207
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source.